{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T04:18:55Z","timestamp":1785039535738,"version":"3.55.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T00:00:00Z","timestamp":1653696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["51,52"],"award-info":[{"award-number":["51,52"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.heliyon.2022.e09630","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T22:33:55Z","timestamp":1654122835000},"page":"e09630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Functional foods: promising therapeutics for Nigerian Children with sickle cell diseases"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0919-2937","authenticated-orcid":false,"given":"Oladeji John","family":"Alabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8782-7902","authenticated-orcid":false,"given":"Fikayo Noah","family":"Adegboyega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2861-5253","authenticated-orcid":false,"given":"Dolapo Samuel","family":"Olawoyin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwakemi Arinola","family":"Babatunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.heliyon.2022.e09630_bib1","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM199709113371107","article-title":"Pathogenesis and treatment of sickle cell disease","volume":"337","author":"Bunn","year":"1997","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2022.e09630_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/269659","article-title":"Phytomedicines and nutraceuticals: alternative therapeutics for sickle cell anemia","author":"Imaga","year":"2013","journal-title":"Sci. World J."},{"key":"10.1016\/j.heliyon.2022.e09630_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40795-018-0241-z","article-title":"Dietary intakes and nutritional status of children with sickle cell disease at the Princess Marie Louise Hospital, Accra \u2013 a survey","volume":"4","author":"Boadu","year":"2018","journal-title":"BMC Nutr."},{"key":"10.1016\/j.heliyon.2022.e09630_bib4","first-page":"53","article-title":"Sickle cell disease","volume":"1","author":"Steinberg","year":"2004","journal-title":"Hematology"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e09630_bib5","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2013.062","article-title":"Sickle cell disease: management options and challenges in developing countries","volume":"5","author":"Ansong","year":"2013","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e09630_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12916-020-01879-1","article-title":"Association of sickle cell disease with anthropometric indices among under-five children: evidence from 2018 Nigeria Demographic and Health Survey","volume":"19","author":"Islam","year":"2021","journal-title":"BMC Med."},{"issue":"7526","key":"10.1016\/j.heliyon.2022.e09630_bib7","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/515S10a","article-title":"Perspective: we need a global solution","volume":"515","author":"Odame","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2022.e09630_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1744-8603-6-2","article-title":"Psychosocial impact of sickle cell disorder: perspectives from a Nigerian setting","volume":"6","author":"Anie","year":"2010","journal-title":"Glob. Health"},{"issue":"6 Suppl 4","key":"10.1016\/j.heliyon.2022.e09630_bib9","doi-asserted-by":"crossref","first-page":"S398","DOI":"10.1016\/j.amepre.2011.09.013","article-title":"Sickle cell disease in Africa: a neglected cause of early childhood mortality","volume":"41","author":"Grosse","year":"2011","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.heliyon.2022.e09630_bib10","series-title":"Dictionary of Mythology Folklore and Symbols","author":"Jones","year":"1961"},{"key":"10.1016\/j.heliyon.2022.e09630_bib11","first-page":"2","article-title":"Phyto-Medicine in gene(s) targeting future direction for sickle cell disease management","volume":"5","author":"Alli","year":"2016","journal-title":"Hered. Genet."},{"key":"10.1016\/j.heliyon.2022.e09630_bib12","first-page":"1947","article-title":"Antisickling agent in an extract of unripe pawpaw (Carica papaya): is it real?","volume":"5","author":"Oduola","year":"2006","journal-title":"Afr. J. Biotechnol."},{"key":"10.1016\/j.heliyon.2022.e09630_bib13","first-page":"97","article-title":"Analyses of antisickling potency of Carica papaya dried leaf extract and fractions","volume":"2","author":"Imaga","year":"2010","journal-title":"J.\u00a0Pharmacogn. Phytotherapy"},{"key":"10.1016\/j.heliyon.2022.e09630_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/inthealth\/iht022","article-title":"Current sickle cell disease management practices in Nigeria","volume":"6","author":"Galadanci","year":"2015","journal-title":"Int. Health"},{"key":"10.1016\/j.heliyon.2022.e09630_bib15","doi-asserted-by":"crossref","first-page":"7914","DOI":"10.1155\/2015\/791498","article-title":"Management of sickle cell disease: a review for physician education in Nigeria (sub-saharan Africa)","volume":"2015","author":"Adewoyin","year":"2015","journal-title":"Anemia"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e09630_bib16","first-page":"78","article-title":"Albumin and globulin fractions from black bean seeds (Phaseolus vulgaris L.) used in the management of sickle cell disease (SCD) in the west region of Cameroon have antisickling and antioxidant properties","volume":"3","author":"Kenmoe","year":"2020","journal-title":"Biotechnol. Biomed."},{"key":"10.1016\/j.heliyon.2022.e09630_bib17","series-title":"Sickle Cell Disease in Cuba","first-page":"13","author":"Svarch","year":"2001"},{"key":"10.1016\/j.heliyon.2022.e09630_bib18","article-title":"Biochemical investigation of the upstream anti-sickling mechanisms of soursop (Annona muricata): 15-acetyl guanacone as an inhibitor of deoxyhaemoglobin polymerisation","author":"Kingsley","year":"2020","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.heliyon.2022.e09630_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.neuroscience.2004.03.055","article-title":"Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea","volume":"126","author":"Xu","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.heliyon.2022.e09630_bib20","article-title":"Emerging therapies in sickle cell disease","author":"Amina","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.heliyon.2022.e09630_bib21","first-page":"30","article-title":"HPLC profiling, in vitro antisickling and antioxidant activities of phenolic compound extracts from black bean seeds (Phaseolus vulgarus L.) used in the management of sickle cell disease in the West Region of Cameroon","volume":"3","author":"Nkenmeni","year":"2019","journal-title":"Int. J. Food Nutr. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e09630_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.30574\/gscbps.2020.11.2.0143","article-title":"Functional foods and bioactive compounds: roles in the prevention, treatment and management of neurodegenerative diseases","volume":"11","author":"Teibo","year":"2020","journal-title":"GSC Biol. Pharmaceut. Sci."},{"key":"10.1016\/j.heliyon.2022.e09630_bib23","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/S0021-9258(18)67935-9","article-title":"The structure of human hemoglobin. VI. The sequence of amino acids in the tryptic peptides of the beta chain","volume":"238","author":"Goldstein","year":"1963","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.heliyon.2022.e09630_bib24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","article-title":"Pathophysiology of sickle cell disease","volume":"14","author":"Sundd","year":"2019","journal-title":"Ann. Rev. Pathol,"},{"key":"10.1016\/j.heliyon.2022.e09630_bib25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fphys.2020.00435","article-title":"Recent advances in the treatment of sickle cell disease","volume":"11","author":"Cisneros","year":"2020","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e09630_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ajh.21952","article-title":"Reconstructing sickle cell disease: a data-based analysis of the \"hyperhemolysis paradigm\" for pulmonary hypertension from the perspective of evidence-based medicine","volume":"86","author":"Hebbel","year":"2011","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e09630_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/ejh.13212","article-title":"Insight into the complex pathophysiology of sickle cell anaemia and possible treatment","volume":"102","author":"Piccin","year":"2019","journal-title":"Eur. J. Haematol."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e09630_bib28","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI89741","article-title":"Intravascular hemolysis and the pathophysiology of sickle cell disease","volume":"127","author":"Kato","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e09630_bib29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1182\/asheducation-2018.1.493","article-title":"New insights into the pathophysiology and development of novel therapies for sickle cell disease","volume":"2018","author":"Moerdler","year":"2018","journal-title":"Hematology. Americ an Society of Hematology. Edu. Program"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e09630_bib30","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nm.1939","article-title":"Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury","volume":"15","author":"Hidalgo","year":"2009","journal-title":"Nat. Med."},{"issue":"9757","key":"10.1016\/j.heliyon.2022.e09630_bib31","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e09630_bib32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","article-title":"Heme triggers TLR4 signaling leading to endothelial cell activation and vaso- occlusion in murine sickle cell disease","volume":"123","author":"Belcher","year":"2014","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.heliyon.2022.e09630_bib33","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1182\/blood-2013-06-510180","article-title":"Molecular mechanisms underlying synergistic adhesion of sickle red blood cells by hypoxia and low nitric oxide bioavailability","volume":"123","author":"Gutsaeva","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e09630_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/ejh.13430","article-title":"The vaso-occlusive pain crisis in sickle cell disease: definition, pathophysiology, and management","volume":"105","author":"Darbari","year":"2020","journal-title":"Eur. J. Haematol."},{"issue":"2-3","key":"10.1016\/j.heliyon.2022.e09630_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3233\/CH-189011","article-title":"Autonomic nervous system involvement in sickle cell disease","volume":"68","author":"Coates","year":"2018","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e09630_bib36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0950-3536(98)80074-7","article-title":"Pathophysiology of sickle cell disease","volume":"11","author":"Steinberg","year":"1998","journal-title":"Bailliere. Clin. Haematol."},{"issue":"9442","key":"10.1016\/j.heliyon.2022.e09630_bib37","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(04)17192-4","article-title":"Sickle-cell disease","volume":"364","author":"Stuart","year":"2004","journal-title":"Lancet (London, England)"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e09630_bib38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/ajh.22012","article-title":"Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management","volume":"86","author":"Nur","year":"2011","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e09630_bib39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10739680802279394","article-title":"Sickle red cell-endothelium interactions","volume":"16","author":"Kaul","year":"2009","journal-title":"Microcirculation (N. Y.)"},{"issue":"12","key":"10.1016\/j.heliyon.2022.e09630_bib40","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nri2873","article-title":"Sterile inflammation: sensing and reacting to damage","volume":"10","author":"Chen","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"39","key":"10.1016\/j.heliyon.2022.e09630_bib41","doi-asserted-by":"crossref","first-page":"E4110","DOI":"10.1073\/pnas.1405023111","article-title":"Hemolysis- induced lethality involves inflammasome activation by heme","volume":"111","author":"Dutra","year":"2014","journal-title":"Proc. Nat. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.heliyon.2022.e09630_bib42","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood-2015-09-618538","article-title":"Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology","volume":"127","author":"Zhang","year":"2016","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.heliyon.2022.e09630_bib43","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1182\/blood-2014-07-589283","article-title":"Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease","volume":"125","author":"Camus","year":"2015","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.heliyon.2022.e09630_bib44","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2013-10-529982","article-title":"Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease","volume":"123","author":"Chen","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e09630_bib45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.it.2011.01.005","article-title":"Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation","volume":"32","author":"Krysko","year":"2011","journal-title":"Trends Immunol."},{"issue":"28","key":"10.1016\/j.heliyon.2022.e09630_bib46","doi-asserted-by":"crossref","first-page":"20221","DOI":"10.1074\/jbc.M610737200","article-title":"Characterization of heme as activator of Toll-like receptor 4","volume":"282","author":"Figueiredo","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e09630_bib47","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.4049\/jimmunol.1002400","article-title":"Leukotriene B4 mediates neutrophil migration induced by heme","volume":"186","author":"Monteiro","year":"2011","journal-title":"J.\u00a0Immunol."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e09630_bib48","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1517\/14740338.2015.1088827","article-title":"Hydroxyurea therapy for sickle cell anemia","volume":"14","author":"McGann","year":"2015","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.heliyon.2022.e09630_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.exphem.2020.08.008","article-title":"Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials","volume":"92","author":"Ali","year":"2020","journal-title":"Exp. Hematol."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e09630_bib50","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1053\/j.seminhematol.2020.07.007","article-title":"Transfusion support in patients with sickle cell disease","volume":"57","author":"Sharma","year":"2020","journal-title":"Semin. Hematol."},{"issue":"14","key":"10.1016\/j.heliyon.2022.e09630_bib51","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM198404053101401","article-title":"Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea","volume":"310","author":"Letvin","year":"1984","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e09630_bib52","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1172\/JCI111464","article-title":"Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia","volume":"74","author":"Platt","year":"1984","journal-title":"J.\u00a0Clin. Invest."},{"issue":"10","key":"10.1016\/j.heliyon.2022.e09630_bib53","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1182\/blood.V79.10.2555.2555","article-title":"Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia","volume":"79","author":"Charache","year":"1992","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.heliyon.2022.e09630_bib54","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"9778","key":"10.1016\/j.heliyon.2022.e09630_bib55","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","article-title":"Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)","volume":"377","author":"Wang","year":"2011","journal-title":"Lancet (London, England)"},{"issue":"9","key":"10.1016\/j.heliyon.2022.e09630_bib56","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.3324\/haematol.2018.207530","article-title":"Targeting sickle cell disease root-cause pathophysiology with small molecules","volume":"104","author":"Saunthararajah","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.heliyon.2022.e09630_bib57","first-page":"22","article-title":"Hydroxyurea treatment of sickle cell disease: towards a personalized model-based approach","volume":"5","author":"Pandey","year":"2021","journal-title":"J.\u00a0Transl. Genet. Genom."},{"key":"10.1016\/j.heliyon.2022.e09630_bib58","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1100\/tsw.2008.157","article-title":"Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches","volume":"8","author":"Steinberg","year":"2008","journal-title":"TheScientificWorldJOURNAL"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e09630_bib59","first-page":"273","article-title":"Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia","volume":"89","author":"Covas","year":"2004","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e09630_bib60","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1046\/j.1365-2141.2000.02040.x","article-title":"Hydroxyurea therapy decreases the in vitro adhesion of sickle erythrocytes to thrombospondin and laminin","volume":"109","author":"Hillery","year":"2000","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e09630_bib61","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ajh.1098","article-title":"In vitro exposure to hydroxyurea reduces sickle red blood cell deformability","volume":"67","author":"Huang","year":"2001","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e09630_bib62","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3233\/CH-170280","article-title":"Effects of hydroxyurea on blood rheology in sickle cell anemia: a two-years follow-up study","volume":"67","author":"Lemonne","year":"2017","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e09630_bib63","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.thj.6200049","article-title":"Increased erythropoietin level induced by hydroxyurea treatment of sickle cell patients","volume":"1","author":"Papassotiriou","year":"2000","journal-title":"Hematol. J. : Off. J. Eur. Haematol. Assoc."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e09630_bib64","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1172\/JCI200316672","article-title":"Hydroxyurea induces fetal hemoglobin by the nitric oxide- dependent activation of soluble guanylyl cyclase","volume":"111","author":"Cokic","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"issue":"7","key":"10.1016\/j.heliyon.2022.e09630_bib65","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1182\/blood-2018-03-834440","article-title":"l-Glutamine for sickle cell anemia: more questions than answers","volume":"132","author":"Quinn","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e09630_bib66","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1182\/blood-2007-04-081703","article-title":"Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease","volume":"111","author":"Morris","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e09630_bib67","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1096-8652(199806)58:2<117::AID-AJH5>3.0.CO;2-V","article-title":"Oral L-glutamine therapy for sickle cell anemia: I. Subjective clinical improvement and favorable change in red cell NAD redox potential","volume":"58","author":"Niihara","year":"1998","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.heliyon.2022.e09630_bib68","first-page":"4","article-title":"L- glutamine therapy reduces endothelial adhesion of sickle red blood cells to human umbilical vein endothelial cells","volume":"5","author":"Niihara","year":"2005","journal-title":"BMC Blood Disord."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e09630_bib69","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1715971","article-title":"A\u00a0phase 3 trial of l-glutamine in sickle cell disease","volume":"379","author":"Niihara","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e09630_bib70","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e09630_bib71","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajh.25308","article-title":"Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: a SUSTAIN study analysis","volume":"94","author":"Kutlar","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e09630_bib72","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/acs.bioconjchem.9b00130","article-title":"Interactions of an anti-sickling drug with hemoglobin in red blood cells from a patient with sickle cell anemia","volume":"30","author":"Strader","year":"2019","journal-title":"Bioconjugate Chem."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e09630_bib73","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/bjh.14214","article-title":"GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease","volume":"175","author":"Oksenberg","year":"2016","journal-title":"Br. J. Haematol."},{"issue":"17","key":"10.1016\/j.heliyon.2022.e09630_bib74","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1182\/blood-2018-08-868893","article-title":"A\u00a0phase 1\/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease","volume":"133","author":"Howard","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2022.e09630_bib75","doi-asserted-by":"crossref","unstructured":"Vichinsky, E., Hoppe, C. C., Ataga, K. I., Ware, R. E., Nduba, V., El-Beshlawy, A., Hassab, H., Achebe, M. M., Alkindi, S., Brown, R. C., Diuguid, D. L., Telfer, P., Tsitsikas, D. A., Elghandour, A., Gordeuk, V. R., Kanter, J., Abboud, M. R., Lehrer-Graiwer, J., Tonda, M., Intondi, A., HOPE trial Investigators (2019). A phase 3 randomized trial of voxelotor in sickle cell disease. N. Engl. J. Med. , 381(6), 509\u2013 519.","DOI":"10.1056\/NEJMoa1903212"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e09630_bib76","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/1060028020943059","article-title":"Voxelotor: a novel treatment for sickle cell disease","volume":"55","author":"Herity","year":"2021","journal-title":"Ann. Pharmacother."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e09630_bib77","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1586\/17474086.2014.959922","article-title":"Hydroxyurea therapy contributes to infertility in adult men with sickle cell disease: a review","volume":"7","author":"DeBaun","year":"2014","journal-title":"Expet Rev. Hematol."},{"key":"10.1016\/j.heliyon.2022.e09630_bib78","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3324\/haematol.11515","article-title":"Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males","volume":"93","author":"Berthaut","year":"2008","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e09630_bib79","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.crvi.2012.09.007","article-title":"Nutrition and sickle cell disease","volume":"336","author":"Reid","year":"2013","journal-title":"Comptes Rendus Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e09630_bib80","article-title":"Malnutrition in sickle cell anemia: implications for infection, growth, and maturation","volume":"7","author":"Hyacinth","year":"2013","journal-title":"J.\u00a0Social Behav. Health Sci."},{"issue":"8434","key":"10.1016\/j.heliyon.2022.e09630_bib81","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(85)91677-0","article-title":"Growth retardation in sickle-cell disease treated by nutritional support","volume":"1","author":"Heyman","year":"1985","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e09630_bib82","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00043426-199221000-00008","article-title":"Nutritional status and dietary intake of children with sickle cell anemia","volume":"14","author":"Gray","year":"1992","journal-title":"Am. J. Pediatr. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e09630_bib83","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ajcn\/76.1.218","article-title":"Body composition in children with sickle cell disease","volume":"76","author":"Barden","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"issue":"14","key":"10.1016\/j.heliyon.2022.e09630_bib84","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1080\/10408398.2017.1319794","article-title":"The role of nutrition in the pathophysiology and management of sickle cell disease among children: a review of literature","volume":"58","author":"Ohemeng","year":"2018","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.heliyon.2022.e09630_bib85","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10522-004-2566-z","article-title":"Functional foods, herbs and nutraceuticals: towards biochemical mechanisms of healthy aging","volume":"5","author":"Ferrari","year":"2004","journal-title":"Biogerontology"},{"issue":"27","key":"10.1016\/j.heliyon.2022.e09630_bib86","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.1021\/jf0304324","article-title":"Antioxidant activity of extracts, condensed tannin fractions, and pure flavonoids from Phaseolus vulgaris L. seed coat color genotypes","volume":"51","author":"Beninger","year":"2003","journal-title":"J.\u00a0Agric. Food Chem."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e09630_bib87","first-page":"5872","article-title":"HPLC profiling, in vitro antisickling and antioxidant activities of amino acids from black bean seeds (Phaseolus vulgarus L.) used in the management of Sickle Cell Disease (SCD) in the West Region of Cameroon","volume":"11","author":"Kotue","year":"2019","journal-title":"Int. J. Curr. Res."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e09630_bib88","first-page":"192","article-title":"Ethnobotanicals usages in the management of sickle cell disease (SDC) in some localities of Cameroon","volume":"7","author":"Kotue","year":"2016","journal-title":"Pharmacophore"},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2022.e09630_bib89","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1017\/S0007114512000839","article-title":"Edible dry bean consumption (Phaseolus vulgaris L.) modulates cardiovascular risk factors and diet-induced obesity in rats and mice","volume":"108","author":"Zhu","year":"2012","journal-title":"Br. J. Nutr."},{"issue":"12","key":"10.1016\/j.heliyon.2022.e09630_bib90","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3390\/antiox9121181","article-title":"Phaseolus vulgaris L. Var. Venanzio grown in Tuscany: chemical composition and in vitro investigation of potential effects on colorectal cancer","volume":"9","author":"Finetti","year":"2020","journal-title":"Antioxidants"},{"issue":"8","key":"10.1016\/j.heliyon.2022.e09630_bib91","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1021\/bi00549a005","article-title":"Peptide inhibitors of sickle hemoglobin aggregation: effect of hydrophobicity","volume":"19","author":"Gorecki","year":"1980","journal-title":"Biochemistry"},{"key":"10.1016\/j.heliyon.2022.e09630_bib92","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/NDS.S168257","article-title":"Nutrition in sickle cell disease: recent insights","volume":"11","author":"Umeakunne","year":"2019","journal-title":"Nutr. Diet. Suppl."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e09630_bib93","first-page":"330","article-title":"Sickle cell anemia: a potential nutritional approach for a molecular disease","volume":"16","author":"Ohnishi","year":"2000","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.heliyon.2022.e09630_bib94","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jada.2007.02.015","article-title":"Adequacy of dietary intake declines with age in children with sickle cell disease","volume":"107","author":"Kawchak","year":"2007","journal-title":"J.\u00a0Am. Diet Assoc."},{"issue":"91","key":"10.1016\/j.heliyon.2022.e09630_bib95","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1080\/13880209.2017.1309556","article-title":"Acute and sub-chronic toxicity of Cajanus cajan leaf extracts","volume":"55","author":"Tang","year":"2017","journal-title":"Pharm. Biol."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e09630_bib96","first-page":"111","article-title":"Ethnobiological survey of traditional medicine practice for Circulatory and nervous system related diseases in Oyo State","volume":"2","author":"Borokini","year":"2013","journal-title":"Nigeria\u201dTopclass J. Herbal Med."},{"key":"10.1016\/j.heliyon.2022.e09630_bib97","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0378-8741(81)90021-0","article-title":"A\u00a0Hausa herbal pharmacopoeia: biomedical evaluation of commonly used plant medicines","volume":"4","author":"Etkin","year":"1981","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2022.e09630_bib98","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1021\/np50023a026","article-title":"Flavonoids of Garcinia kola seeds","volume":"45","author":"Iwu","year":"1982","journal-title":"J.\u00a0Nat. Prod."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e09630_bib99","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4314\/eamj.v79i11.8804","article-title":"Antibacterial effect of Zingiber officinale and Garcinia kola on respiratory tract pathogens","volume":"79","author":"Akoachere","year":"2002","journal-title":"East Afr. Med. J."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e09630_bib100","first-page":"107","article-title":"Studies on the effect of aqueous extracts of Garcinia kola seed on the human erythrocytes adenosine triphosphatase of HbAA, HbAS, and HbSS genotypes","volume":"2","author":"Elekwa","year":"2003","journal-title":"Global J. Med. Sci."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e09630_bib101","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4269\/ajtmh.2000.62.590","article-title":"Vitamin a supplementation and other predictors of anemia among children from Dar Es Salaam. Tanzania","volume":"62","author":"Villamor","year":"2000","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.heliyon.2022.e09630_bib102","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40795-018-0241-z","article-title":"Dietary intakes and nutritional status of children with sickle cell disease at the Princess Marie Louise Hospital, Accra \u2013 a survey","volume":"4","author":"Boadu","year":"2018","journal-title":"BMC Nutr."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e09630_bib103","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jpeds.2004.03.051","article-title":"Vitamin a status, hospitalizations, and other outcomes in young children with sickle cell disease","volume":"145","author":"Schall","year":"2004","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.heliyon.2022.e09630_bib104","series-title":"Tips for Preventing Food Poisoning \u201cHerbs\u201d Americas No.1 Guide To Natural Health","first-page":"383","author":"Phyllistin","year":"2000"},{"key":"10.1016\/j.heliyon.2022.e09630_bib105","article-title":"Phytochemicals of garlic: promising candidates for cancer therapy","volume":"123","author":"Zhang","year":"2020","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2022.e09630_bib106","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/ijpvm.IJPVM_437_17","article-title":"Aged garlic and cancer: a systematic review","volume":"9","author":"Miraghajani","year":"2018","journal-title":"Int. J. Prev. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e09630_bib107","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0378-8741(00)00264-6","article-title":"Garlic enhances circulatory antioxidants during 7, 12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis","volume":"72","author":"Balasenthil","year":"2000","journal-title":"J.\u00a0Ethnopharmacol."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e09630_bib108","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.phymed.2015.10.015","article-title":"An umbrella review of garlic intake and risk of cardiovascular disease","volume":"23","author":"Schwingshackl","year":"2016","journal-title":"Phytomedicine : Int. J. phytother. phytopharmacol."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e09630_bib109","first-page":"1005","article-title":"The antisickling effects of some edible vegetables","volume":"3","author":"Nwaoguikpe","year":"2009","journal-title":"Int. J. BiolChemSci."},{"issue":"3 Suppl","key":"10.1016\/j.heliyon.2022.e09630_bib110","doi-asserted-by":"crossref","first-page":"803S","DOI":"10.1093\/jn\/136.3.803S","article-title":"Aged garlic extract is a potential therapy for sickle-cell anemia","volume":"136","author":"Takasu","year":"2006","journal-title":"J.\u00a0Nutr."},{"issue":"3s","key":"10.1016\/j.heliyon.2022.e09630_bib111","article-title":"In vitro effects of aged garlic extract and other nutritional supplements on sickle erythrocytes","volume":"131","author":"Ohnishi","year":"2001","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.heliyon.2022.e09630_bib112","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12986-016-0109-7","article-title":"Precipitating factors and targeted therapies in combating the perils of sickle cell disease\u2014 a special nutritional consideration","volume":"13","author":"Khan","year":"2016","journal-title":"Nutr. Metabol."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e09630_bib113","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3945\/ajcn.112.036319","article-title":"Effect of omega-3 (n-3) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial","volume":"97","author":"Daak","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.heliyon.2022.e09630_bib114","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11883-004-0087-5","article-title":"Omega-3 fatty acids and implantation Current","volume":"6","author":"Mori","year":"2004","journal-title":"Atherosclero Rep."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e09630_bib115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/1871529X10909040271","article-title":"A\u00a0systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis","volume":"9","author":"Hebbel","year":"2009","journal-title":"Cardiovasc. Haematol. Disord. - Drug Targets"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e09630_bib116","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1055\/s-0031-1273087","article-title":"Thrombosis and sickle cell disease","volume":"37","author":"De Franceschi","year":"2011","journal-title":"Semin. Thromb. Hemost."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e09630_bib117","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bjh.12336","article-title":"Interplay between coagulation and vascular inflammation in sickle cell disease","volume":"162","author":"Sparkenbaugh","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.heliyon.2022.e09630_bib118","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3324\/haematol.2015.124586","article-title":"Dietary v-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease","volume":"100","author":"Kalish","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.heliyon.2022.e09630_bib119","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00277-005-1023-7","article-title":"Blood mononuclear cells and platelets have abnormal fatty acid composition in homozygous sickle cell disease","volume":"84","author":"Ren","year":"2005","journal-title":"Ann. Hematol."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e09630_bib120","first-page":"102","article-title":"Antisickling property of Carica papaya leaf extract","volume":"3","author":"Imaga","year":"2009","journal-title":"Afr. J. Biochem. Res."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e09630_bib121","first-page":"639","article-title":"Antisickling and toxicological profiles of leaf and stem of Parquetina nigrescens L","volume":"4","author":"Imaga","year":"2010","journal-title":"J.\u00a0Med. Plants Res."},{"issue":"21","key":"10.1016\/j.heliyon.2022.e09630_bib122","first-page":"2217","article-title":"Assessment of antioxidation potential of selected plants with antisickling property","volume":"4","author":"Imaga","year":"2010","journal-title":"J.\u00a0Med. Plants Res."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e09630_bib123","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/ptr.1026","article-title":"The kinetics of reversal of pre-sickled erythrocytes by the aqueous extract of Cajanus cajan seeds","volume":"16","author":"Ogoda Onah","year":"2002","journal-title":"Phytother Res. : PTR"},{"issue":"7","key":"10.1016\/j.heliyon.2022.e09630_bib124","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jfca.2007.03.009","article-title":"Gas chromatography-mass spectrometry analysis of phenolic compounds from Carica papaya L. leaf","volume":"20","author":"Canini","year":"2007","journal-title":"J.\u00a0Food Compos. Anal."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e09630_bib125","doi-asserted-by":"crossref","first-page":"e05571","DOI":"10.1016\/j.heliyon.2020.e05571","article-title":"Phytochemical investigation, anti-inflammatory, antipyretic and antinociceptive activities of Zanthoxylum armatum DC extracts-in vivo and in vitro experiments","volume":"6","author":"Alam","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2022.e09630_bib126","series-title":"Traditional Herbal Management of Sickle Cell Anemia: Lessons from Nigeria. Anemia","first-page":"607436","author":"Ameh","year":"2012"},{"key":"10.1016\/j.heliyon.2022.e09630_bib127","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jep.2008.09.012","article-title":"Antisickling activity of anthocyanins from Bombax pentadrum, Ficus capensis and Ziziphus mucronata: photodegradation effect","volume":"120","author":"Mpiana","year":"2008","journal-title":"J.\u00a0Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e09630_bib128","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1078\/0944-7113-00040","article-title":"Double-blind, placebo-controlled, randomised cross-over clinical trial of NIPRISAN in patients with sickle cell disorder","volume":"8","author":"Wambebe","year":"2001","journal-title":"Phytomedicine"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022009185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022009185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:12:13Z","timestamp":1776773533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844022009185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":128,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2405844022009185"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09630","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional foods: promising therapeutics for Nigerian Children with sickle cell diseases","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e09630"}}